Bourgeon Capital Management’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-15,100
| Closed | -$22.2K | – | 340 |
|
|
2023
Q4 | $22.2K | Hold |
15,100
| – | – | ﹤0.01% | 201 |
|
|
2023
Q3 | $18.3K | Hold |
15,100
| – | – | ﹤0.01% | 202 |
|
|
2023
Q2 | $21.9K | Sell |
15,100
-10,500
| -41% | -$15.2K | 0.01% | 202 |
|
|
2023
Q1 | $37.1K | Buy |
25,600
+12,500
| +95% | +$18.1K | 0.01% | 157 |
|
|
2022
Q4 | $22.7K | Sell |
13,100
-7,500
| -36% | -$13K | 0.01% | 193 |
|
|
2022
Q3 | $41K | Buy |
20,600
+3,000
| +17% | +$5.97K | 0.01% | 143 |
|
|
2022
Q2 | $13K | Sell |
17,600
-45,496
| -72% | -$33.6K | ﹤0.01% | 212 |
|
|
2022
Q1 | $549K | Buy |
63,096
+11,850
| +23% | +$103K | 0.12% | 70 |
|
|
2021
Q4 | $820K | Buy |
51,246
+9,500
| +23% | +$152K | 0.17% | 67 |
|
|
2021
Q3 | $769K | Buy |
+41,746
| New | +$769K | 0.16% | 68 |
|
|
2021
Q1 | – | Sell |
-15,341
| Closed | -$297K | – | 307 |
|
|
2020
Q4 | $297K | Buy |
+15,341
| New | +$297K | 0.07% | 90 |
|